FDA Seeks to Pull Nearly 250 ANDAs Over Unsubmitted Annual Reports

FDA Seeks to Pull Nearly 250 ANDAs Over Unsubmitted Annual Reports

Source: 
RAPS.org
News Tags: 
snippet: 

The US Food and Drug Administration (FDA) on Wednesday said it plans to withdraw the approval of 249 abbreviated new drug applications (ANDAs) after their manufacturers repeatedly failed to submit annual reports for the generic drugs.